Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2026.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova's Board of Directors has approved the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director for a further term of three years, effective June 1, 2026. Both appointments are subject to shareholder approval at the upcoming general meeting. Mr. Priyavrat Bhartia (49 years old) has been associated with the company since May 2017 and brings around 29 years of industry experience, holding degrees from Dartmouth College and Stanford University. Mr. Arjun Shanker Bhartia (39 years old), a Brown University graduate, has been on the board since May 2017 and previously worked at Bain & Company. Both are members of the promoter Bhartia family.
This is a routine corporate governance action confirming continuity in leadership. The re-appointment of experienced promoter family members provides stability in company management and is unlikely to have any immediate impact on the stock price.